These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24034743)

  • 1. On a reusable and multilevel methodology for modeling and simulation of pharmacokinetic-physiological systems: a preliminary study.
    Rodrigues Matos T; Prado-Velasco M; Navarro JM; Vallez C
    Comput Biol Med; 2013 Oct; 43(10):1512-22. PubMed ID: 24034743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study design and simulation approach.
    Läer S; Meibohm B
    Handb Exp Pharmacol; 2011; 205():125-48. PubMed ID: 21882109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual center for renal support: technological approach to patient physiological image.
    Prado M; Roa L; Reina-Tosina J; Palma A; Milán JA
    IEEE Trans Biomed Eng; 2002 Dec; 49(12):1420-30. PubMed ID: 12542237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.
    Zhao P; Zhang L; Grillo JA; Liu Q; Bullock JM; Moon YJ; Song P; Brar SS; Madabushi R; Wu TC; Booth BP; Rahman NA; Reynolds KS; Gil Berglund E; Lesko LJ; Huang SM
    Clin Pharmacol Ther; 2011 Feb; 89(2):259-67. PubMed ID: 21191381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-quantitative simulation for reasoning about physiological models of drug kinetics and effects.
    Leemann TD; Blaschke TF
    Schweiz Med Wochenschr; 1990 Dec; 120(49):1849-52. PubMed ID: 2263925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
    Peters SA; Ungell AL; Dolgos H
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of physiologically based pharmacokinetic modeling in regulatory review.
    Huang SM; Rowland M
    Clin Pharmacol Ther; 2012 Mar; 91(3):542-9. PubMed ID: 22318616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The virtual laboratory approach to pharmacokinetics: design principles and concepts.
    Huisinga W; Telgmann R; Wulkow M
    Drug Discov Today; 2006 Sep; 11(17-18):800-5. PubMed ID: 16935747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies.
    Moss DM; Marzolini C; Rajoli RK; Siccardi M
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1203-17. PubMed ID: 25872900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of modeling and simulation in pediatric investigation plans.
    Manolis E; Osman TE; Herold R; Koenig F; Tomasi P; Vamvakas S; Saint Raymond A
    Paediatr Anaesth; 2011 Mar; 21(3):214-21. PubMed ID: 21244569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PC-based graphical simulator for physiological pharmacokinetic models.
    Wada DR; Stanski DR; Ebling WF
    Comput Methods Programs Biomed; 1995 Apr; 46(3):245-55. PubMed ID: 7656558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A methodology for eliciting and modeling exceptions.
    Peleg M; Somekh J; Dori D
    J Biomed Inform; 2009 Aug; 42(4):736-47. PubMed ID: 19442762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-photosynthesis: web-based platform for modeling of complex photosynthetic processes.
    Safránek D; Cervený J; Klement M; Pospíšilová J; Brim L; Lazár D; Nedbal L
    Biosystems; 2011 Feb; 103(2):115-24. PubMed ID: 21073914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The virtual physiological human: building a framework for computational biomedicine I. Editorial.
    Clapworthy G; Viceconti M; Coveney PV; Kohl P
    Philos Trans A Math Phys Eng Sci; 2008 Sep; 366(1878):2975-8. PubMed ID: 18559315
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach.
    Yeo KR; Jamei M; Rostami-Hodjegan A
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):143-57. PubMed ID: 23473592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic modeling.
    Strand SE; Zanzonico P; Johnson TK
    Med Phys; 1993; 20(2 Pt 2):515-27. PubMed ID: 8492760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward computational systems biology.
    You L
    Cell Biochem Biophys; 2004; 40(2):167-84. PubMed ID: 15054221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: a conceptual framework.
    Dahl SG; Aarons L; Gundert-Remy U; Karlsson MO; Schneider YJ; Steimer JL; Trocóniz IF
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):2-12. PubMed ID: 19686541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.